Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - OPERATING EXPENSES
Operating Expenses ALLO - Allogene Therapeutics, Inc.
328 M
LAST VALUE
5.55%
2 YEAR CAGR
11.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR